Working… Menu

Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma (ALECSAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02799238
Recruitment Status : Completed
First Posted : June 14, 2016
Last Update Posted : April 30, 2020
Information provided by (Responsible Party):
CytoVac A/S

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 14, 2019
Actual Study Completion Date : February 24, 2020